Algernon Pharmaceuticals Inc. (OTCMKTS:AGNPF) Sees Large Increase in Short Interest

Algernon Pharmaceuticals Inc. (OTCMKTS:AGNPF) saw a large growth in short interest in the month of January. As of January 31st, there was short interest totalling 5,100 shares, a growth of 363.6% from the January 15th total of 1,100 shares. Based on an average daily trading volume, of 13,000 shares, the short-interest ratio is presently 0.4 days.

Algernon Pharmaceuticals Stock Performance

Algernon Pharmaceuticals stock traded up $0.01 during mid-day trading on Wednesday, hitting $0.09. The company’s stock had a trading volume of 5,165 shares, compared to its average volume of 30,976. Algernon Pharmaceuticals has a one year low of $0.04 and a one year high of $0.12. The company has a 50 day moving average of $0.05 and a 200-day moving average of $0.06.

About Algernon Pharmaceuticals

Algernon Pharmaceuticals Inc operates as a clinical stage pharmaceutical development company. It focuses on the areas of non-alcoholic steatohepatitis, chronic kidney disease, inflammatory bowel disease, idiopathic pulmonary fibrosis, chronic cough, pancreatic and small cell lung cancer, and acute lung injury in Canada and Australia.